THIS WAS RELEASED THIS MORNING. .0001 - .0002 NEWS:

New Post Public Reply Private Reply Replies (2) Message Board
OldSaltDawg
240
THIS WAS RELEASED THIS MORNING.

.0001 - .0002

NEWS: Halitron, Inc. - HAON, Up List Imminent as Revenues Surge, Expenses Fall
Print
Alert
Miami, FL -- December 11, 2017 -- InvestorsHub NewsWire -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Halitron, Inc. (OTC Pink: HAON).

HAON may not be at these levels much longer.

See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
http://emerginggrowth.com/?s=haon

Halitron, Inc. (OTC Pink: HAON) just announced Its first shareholder update since last releasing its financials.

HAON stated that management is expecting quarterly revenue to surge over $300,000 in its first reporting period since the acquisition of The Hopp Company assets earlier in the year.

Margins are also expected to increase due to its reduction of a manufacturing cell expenses by 65% after a move from Newton CT, to New Hide Park NY.

Management further stated that its 2017 audit to be completed during the early part of 2018, with an up list to the OTCQB following shortly after.

Financial Highlights from its Q3 Report:
The sale of two Halitron brands to Life’s Time Capsule Services, Inc. (“LTCP”), the acquisition of The Hopp Companies, Inc’s (“Hopp Companies”) assets, and the previous two acquisitions of the brands are now listed on the Company’s unaudited Balance Sheet as of September 30, 2017, with the following selected data points:


LTCP Preferred Stock C $ 3,000,000
56,115,000 Restricted Common Shares
of LTCP (valued at par value) * $ 56,115
Hopp Goodwill $ 700,000
Pieces In Places Goodwill $ 28,297
Cinch Signs Goodwill $ 611,622
Total $ 4,396,034

* LTCP’s common shares have been trading at around $0.05/share, and are expected to have market value in excess of par value, and the Company’s holding of such shares is subject to a pending impairment analysis. 56 million common shares of LTCP hold a current value of $2.8 million @.05 per share.
Halitron is now generating sales revenue, which, accompanied with its anticipated ability to raise capital through traditional debt for working capital needs, which management believes will provide the Company the runway it needs to execute the next phase of its business plan.
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'


https://twitter.com/twitter/statuses/957208055766241280
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading